---
title: TearScience
slug: tearscience
qid: 
snapshot: enwiki-001304956303
content_hash: 
license: CC BY-SA 4.0
source: https://en.wikipedia.org/w/index.php?oldid=1304956303
tags: [111278769, 21493616, 33601774, 37645845, 46945663, 5367527, 55308192, 5565560]
---

# TearScience

> [!note] Provenance
> Snapshot `enwiki-001304956303` · content root `…`
> Derived from <https://en.wikipedia.org/w/index.php?oldid=1304956303> · Licensed CC BY-SA 4.0

TearScience is an American company founded in 2005 that develops, manufactures and markets ophthalmic medical devices aiding in the identification and treatment of meibomian gland dysfunction, which can lead to dry eye disease, which is a condition that affect as many as 25 million Americans. The company's Lipiflow System was FDA cleared in June 2011 for treating meibomian gland dysfunction and is currently installed in over 250 locations across the globe. The company is headquartered in Morrisville, North Carolina.

TearScience is an American company founded in 2005 that develops, manufactures and markets ophthalmic medical devices aiding in the identification and treatment of meibomian gland dysfunction, which can lead to dry eye disease, which is a condition that affect as many as 25 million Americans. The company's Lipiflow System was FDA cleared in June 2011 for treating meibomian gland dysfunction and is currently installed in over 250 locations across the globe. The company is headquartered in Morrisville, North Carolina. Wall Street Journal "More Dry Eyes in the House" Review of Optometry "Dry Eye Measurement Lipiview Ocular Surface Interferometer" MedCity News "Medical device dry-eye treatment LipiFlow wins FDA approval
